MAPELLI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 304
EU - Europa 299
AS - Asia 50
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 673
Nazione #
US - Stati Uniti d'America 295
SE - Svezia 128
IT - Italia 102
CN - Cina 30
AU - Australia 17
DE - Germania 17
FI - Finlandia 16
CA - Canada 9
FR - Francia 9
IE - Irlanda 8
GB - Regno Unito 7
SG - Singapore 6
PL - Polonia 5
HK - Hong Kong 4
ID - Indonesia 3
JP - Giappone 3
BG - Bulgaria 2
EU - Europa 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
IN - India 1
IR - Iran 1
NL - Olanda 1
PE - Perù 1
RU - Federazione Russa 1
VN - Vietnam 1
Totale 673
Città #
Milan 52
Ashburn 47
New York 40
Shanghai 28
Lawrence 26
Princeton 26
Helsinki 16
Rome 13
Dublin 8
Washington 7
Canberra 6
London 6
Philadelphia 6
Adelaide 5
Hamilton 5
Lublin 5
Seattle 5
Hong Kong 4
Montecchio Maggiore 4
Pesaro 4
Bandung 3
Chiusi 3
Hanover 3
Lissone 3
Los Angeles 3
Sydney 3
Council Bluffs 2
Engelhard 2
Mountain View 2
Pescara 2
Razgrad 2
Toronto 2
Vigonza 2
Andover 1
Bergamo 1
Black River Falls 1
Boardman 1
Brussels 1
Changsha 1
Columbus 1
Frankfurt am Main 1
Hai Duong 1
Hangzhou 1
Hessisch Oldendorf 1
Houston 1
Lima 1
Melbourne 1
Menlo Park 1
Moncton 1
Moscow 1
Neyagawa 1
Pune 1
Romford 1
Sarno 1
Secaucus 1
Stratford 1
Tonekabon 1
Torrile 1
Treviso 1
Totale 371
Nome #
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 40
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 34
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 33
Nuclear medicine in prostate cancer management 31
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 26
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 26
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 25
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 24
Clinical implication of multimodality imaging of aortic root intramural hematoma 23
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 23
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 21
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 21
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 20
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 20
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 19
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 19
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 18
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 18
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 18
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 18
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 17
Pancreatic metastases from primary ileal NET only detected by 68Ga-DOTATOC PET/CT 17
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 16
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 16
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 15
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 14
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 14
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 14
Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis 14
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 14
DETECTION OF BONE METASTASES AND EVALUATION OF THERAPY RESPONSE IN PROSTATE CANCER PATIENTS BY RADIOLABELLED CHOLINE PET/CT 14
PET/MRI and prostate cancer 11
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 11
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 11
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL 11
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 10
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 10
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 9
The role of positron emission tomography/computed tomography (Pet/ct) for staging and disease response assessment in localized and locally advanced pancreatic cancer 9
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 8
Optical imaging in lung cancer—follow the light, towards molecular imaging–guided precision surgery 8
PET/MRI 7
Radiomics and artificial intelligence 6
Imaging in evaluation of response to neo-adjuvant treatment 6
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 4
POSITRON EMISSION TOMOGRAPHY/MAGNETIC RESONANCE IMAGING 4
TECNICHE, METODOLOGIE, APPLICAZIONI DIAGNOSTICA PER IMMAGINI 4
PET/MRI in gynecological tumors 3
Detection of bone metastases and evaluation of therapy response in prostate cancer patients by radiolabelled choline PET/CT 1
Totale 775
Categoria #
all - tutte 7.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.669


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 1 0 0 0 6 1 0
2020/20217 0 0 0 5 0 2 0 0 0 0 0 0
2021/202268 0 6 0 14 9 3 9 9 7 8 1 2
2022/2023310 63 52 21 29 17 27 23 33 4 19 3 19
2023/2024380 40 23 87 53 34 68 16 40 8 11 0 0
Totale 775